The Effect of Patient-Controlled TEAS vs Sham TEAS for Improve Quality of Life in Patients With Cancer Pain

ConditionCancer Pain
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorYi Liang

About this trial

The conduct of a pilot trial is of great significance as a means of assessing the feasibility and harmonization of the research and is a very necessary precursor to the better conduct of formal trials. The primary aim of this pilot study is to assess the feasibility of a PC-TEAS in improving the quality of life of cancer patients with pain, with the aspiration of providing process evidence base and an assessment of the intervention for conducting a formal trial. the secondary outcome is to assess the clinical efficacy of the PC-TEAS.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • Transcutaneous electrical acupoint stimulation

    Other intervention

    The 4 patches of the transcutaneous acupoint electrical stimulator were pasted on two pairs of acupuncture points, the output frequency was adjusted to 2Hz, the intensity was up to 50ma, the single intervention time was 30 minutes, and another group of acupuncture points was replaced after completion, and the rest of the operations were the same as above, with a total intervention time of 1 hour.

  • sham Transcutaneous electrical acupoint stimulation

    Other intervention

    The patch is fixed on the acupuncture point to turn on the instrument, but there is no current output

Treatment groups

94 Participants
are divided into 2 treatment groups
Group A: TEASActive comparator 1 intervention
Group B: sham TEASPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Trial feasibility

The feasibility of the proposed approach will be evaluated by the number who agreed to participate in the trial.

Time frame
week 4

Secondary outcomes

1

the changes of EORTC QLQ-C30 score from baseline

EORTC QLQ-C30 is a specific scale for the quality of life of cancer patients and contains 30 questions. It encompasses three dimensions of assessment which are global quality of life assessment, function assessment (physical, role, emotional, cognitive, social), and symptom assessment (fatigue, nausea, vomiting, pain, dyspnea, sleep, appetite, constipation, diarrhea, and financial). Standardized scores with values ranging from 0 to 100. Higher scores in global quality of life and functioning are indicative of an improved quality of life, whereas higher scores in symptom are associated with poorer health outcomes.

Time frame
week 4, week 8, week 12
2

the changes in BPI score of mean pain, severe Pain, least pain and current pain from baesline

Brief Pain Inventory (BPI) scale is a commonly used scale for evaluating pain. Assess the patient's mean pain, severe pain, least pain score over the past week, and current level of pain. Scores range from 1-10, with higher scores indicating more severe pain.

Time frame
week 4, week 8, week 12
3

the amounts of analgesics used

Changes in Patient Medication Dosage Compared to Baseline.

Time frame
week 4, week 8, week 12
4

Index of spontaneous bowel movements

Spontaneous bowel movements (SBM) refer to bowel movements that have occurred within the past 24 hours without the use of laxatives.Record the number of spontaneous bowel movements of the subject in the past week. Bowel Function Index (BFI) in clinical practice. Specially used to evaluate constipation caused by opioid drugs, the subject's difficulty in defecation and feeling of incomplete defecation in the past week will be recorded. The overall satisfaction rating of defecation.

Time frame
week 4, week 8, week 12

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Yi Liang

Lead sponsor

The Third Affiliated hospital of Zhejiang Chinese Medical University

Sponsor institution

This trial is not recruiting at the moment. You can still explore other options: